Skip to main content

SurpassMD vs Remedy Meds: Flat Low Pricing vs Premium Access

SurpassMD and Remedy Meds sit at opposite ends of compounded GLP-1 pricing. SurpassMD offers semaglutide as low as $114/month and tirzepatide as low as $177/month — flat rates that stay the same across every dose — plus 48-hour cold shipping and a needle-free oral semaglutide option. Remedy Meds charges $299 and $399 per month respectively, billed month-to-month, and its differentiator is unlimited provider messaging and video access at the highest price in this set. Remedy Meds also drew a September 2025 FDA warning letter over marketing that implied its compounded meds were FDA-approved equivalents. The comparison comes down to what that unlimited provider access is worth to you.

Side-by-Side Comparison (July 2026)

FeatureSurpassMDRemedy Meds
SemaglutideAs low as $114/mo$299/mo
TirzepatideAs low as $177/mo$399/mo
Dose escalationFlat — no increase with doseFlat monthly rate
Oral optionOral semaglutide (needle-free)None
Brand-name optionNoneOzempic $1,299, Zepbound $1,399
Provider accessAsync review + supportUnlimited video + messaging
BillingMonth-to-month, cancel anytimeMonth-to-month
PaymentCash-pay; HSA/FSA & KlarnaCash-pay
ShippingCold, within 48 hours3-7 business days
Regulatory historyNew brand (2026), no actionsFDA warning letter Sept 2025 (marketing)
Coverage50 states + DCMost states

What the $175-215/Month Premium Actually Buys

Remedy Meds' unlimited-access model is the entire value proposition. In practice, most GLP-1 patients contact their provider heavily in months one to three (titration, nausea management, injection questions) and rarely after stabilizing. That usage curve suggests a hybrid strategy: if you expect a rough adjustment period, Remedy's access has value early; once stable, SurpassMD's flat rate delivers the identical molecule for far less — and because SurpassMD's price stays the same across every dose, that saving does not erode as you titrate up. Provider-switching between telehealth platforms is routine — the new platform re-runs intake and continues your current dose.

For managing the side effects that drive most provider contact, see our guides to GLP-1 side effects and how long semaglutide side effects last.

Verdict: Which Should You Choose?

SurpassMD wins on price — a flat low rate that does not climb with your dose — plus shipping speed and the oral semaglutide option, all with cancel-anytime billing. Remedy Meds earns its premium only for patients who will genuinely use unlimited provider access or want brand-name medication on the same platform. The September 2025 FDA warning letter is worth weighing when evaluating how each platform communicates about compounded medication risk.

Full reviews: SurpassMD review and Remedy Meds review. See the ranked best GLP-1 telehealth providers and the full price comparison.

Frequently Asked Questions

SurpassMD is $185/month cheaper for compounded semaglutide (as low as $114 vs $299) and $222/month cheaper for compounded tirzepatide (as low as $177 vs $399). Over a 12-month course, that is roughly $2,220-2,664. SurpassMD prices are flat — the same low rate applies across every dose, with no increase as you titrate up. Remedy Meds bills month-to-month only, with no prepay tiers.

Unlimited video calls and messaging with the care team between monthly check-ins — genuinely unusual in the category, where most platforms cap provider contact. Remedy Meds also offers brand-name Ozempic ($1,299) and Zepbound ($1,399), which SurpassMD does not. For patients who expect heavy side-effect management or frequent titration questions, unlimited access has real value.

Yes. In September 2025 the FDA cited Remedy Meds for misbranding: marketing that implied its compounded semaglutide and tirzepatide were FDA-approved equivalents of brand-name drugs. The letter concerned advertising claims, not product safety findings, and the company continues to operate. It is still a relevant signal about marketing practices when comparing platforms.

No. SurpassMD pricing is flat — compounded semaglutide as low as $114/month and tirzepatide as low as $177/month, and that rate does not rise as you titrate to a higher dose. The "as low as" rate reflects the longest-subscription option. You can cancel anytime. Remedy Meds bills a single month-to-month rate with no prepay tiers.

SurpassMD ships cold-chain within 48 hours of provider approval to all 50 states plus DC; Remedy Meds quotes 3-7 business days. Both ship compounded injectables cold-packed with tracking, and both include shipping in the monthly price. SurpassMD also supports HSA/FSA and Klarna, and includes nutrition guidance.

On price, SurpassMD wins this matchup at every point of comparison, with a flat low rate that does not climb as your dose increases, plus 48-hour shipping and an oral semaglutide option. Remedy Meds makes sense for patients who specifically want unlimited provider access or a brand-name option on the same platform, and who will pay $175-215/month more for it. If you rarely message your provider, that premium buys nothing.

This page is informational and is not medical advice. SurpassMD is operated by Life Vitality LLC, which also owns Peptide Dossier. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed. Pricing verified July 2026 and subject to change.